414 members · 409 US-listed
Best Biotech Platform stocks
−14.8%3-month median
- The Biotech Platform theme has 414 members; their median 3-month return is −14.8%, behind the S&P 500 (+4.7%).
- The 3-month leader is OABI (OmniAb, Inc.) at +140.9%.
- 32% of members trade above their 200-day average; analysts made 569 estimate raises and 602 cuts in 30 days.
Top 10 by 3-month return
Members ranked by price return. Stocks the batch flags for extreme price moves are left out.
| # | Stock | Market cap | 1M | 3M | 12M | Above 200-day |
|---|---|---|---|---|---|---|
| 1 | OABI OmniAb, Inc. · NASDAQ | $714,593,792 | −0.1% | +140.9% | +184.1% | Yes |
| 2 | ABCL AbCellera Biologics Inc. · NASDAQ | $4.0B | −3.2% | +115.9% | +108.9% | Yes |
| 3 | CAI Caris Life Sciences, Inc. · NASDAQ | $9.1B | +2.8% | +106.7% | +2.7% | Yes |
| 4 | ATAI AtaiBeckley Inc. · NASDAQ | $2.7B | +1.7% | +93.4% | +55.7% | Yes |
| 5 | ARCT Arcturus Therapeutics Holdings · NASDAQ | $314,643,360 | −23.0% | +91.2% | −48.5% | Yes |
| 6 | APGE Apogee Therapeutics, Inc. · NASDAQ | $10.2B | +0.7% | +70.3% | +268.8% | Yes |
| 7 | OBIO Orchestra BioMed Holdings, Inc. · NASDAQ | $348,909,792 | −6.7% | +59.5% | +48.8% | Yes |
| 8 | OMER Omeros Corporation · NASDAQ | $1.2B | −22.8% | +58.2% | +97.1% | Yes |
| 9 | HALO Halozyme Therapeutics, Inc. · NASDAQ | $14.2B | +8.4% | +54.4% | +87.8% | Yes |
| 10 | VSTM Verastem, Inc. · NASDAQ | $834,089,280 | +10.0% | +49.0% | +14.8% | Yes |
How broad is the move
Share of members above their moving averages, and analyst estimate changes across the theme.
Above 50-day average19%
Above 200-day average32%
Estimate raises (30d) 569Estimate cuts (30d) 602
Theme median vs S&P 500
Track this theme every day
Hub ranks every member daily and alerts you when a leader breaks out or estimates turn.